<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T04:26:11Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6930305" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6930305</identifier>
        <datestamp>2019-12-27</datestamp>
        <setSpec>scirep</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
              <journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
              <journal-title-group>
                <journal-title>Scientific Reports</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2045-2322</issn>
              <publisher>
                <publisher-name>Nature Publishing Group UK</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6930305</article-id>
              <article-id pub-id-type="pmcid">PMC6930305</article-id>
              <article-id pub-id-type="pmc-uid">6930305</article-id>
              <article-id pub-id-type="pmid">31875018</article-id>
              <article-id pub-id-type="publisher-id">56242</article-id>
              <article-id pub-id-type="doi">10.1038/s41598-019-56242-z</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Advanced glycation end-products regulate extracellular matrix-adipocyte metabolic crosstalk in diabetes</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Strieder-Barboza</surname>
                    <given-names>Clarissa</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Baker</surname>
                    <given-names>Nicki A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Flesher</surname>
                    <given-names>Carmen G.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Karmakar</surname>
                    <given-names>Monita</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Neeley</surname>
                    <given-names>Christopher K.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Polsinelli</surname>
                    <given-names>Dominic</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dimick</surname>
                    <given-names>Justin B.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Finks</surname>
                    <given-names>Jonathan F.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ghaferi</surname>
                    <given-names>Amir A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Varban</surname>
                    <given-names>Oliver A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lumeng</surname>
                    <given-names>Carey N.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>O’Rourke</surname>
                    <given-names>Robert W.</given-names>
                  </name>
                  <address>
                    <email>rorourke@med.umich.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Department of Surgery, </institution><institution>University of Michigan Medical School, </institution></institution-wrap>Ann Arbor, MI USA </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Department of Pediatrics and Communicable Diseases, </institution><institution>University of Michigan Medical School, </institution></institution-wrap>Ann Arbor, MI USA </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Graduate Program in Immunology, </institution><institution>University of Michigan Medical School, </institution></institution-wrap>Ann Arbor, MI USA </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Graduate Program in Cellular and Molecular Biology, </institution><institution>University of Michigan Medical School, </institution></institution-wrap>Ann Arbor, MI USA </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Undergraduate Research Opportunity Program, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI USA </aff>
                <aff id="Aff6"><label>6</label>Department of Surgery, Ann Arbor Veterans Affairs Healthcare System, Ann Arbor, MI USA </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>24</day>
                <month>12</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>24</day>
                <month>12</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2019</year>
              </pub-date>
              <volume>9</volume>
              <elocation-id>19748</elocation-id>
              <history>
                <date date-type="received">
                  <day>27</day>
                  <month>8</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>7</day>
                  <month>12</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2019</copyright-statement>
                <license license-type="OpenAccess">
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <p id="Par1">The adipose tissue extracellular matrix (ECM) regulates adipocyte cellular metabolism and is altered in obesity and type 2 diabetes, but mechanisms underlying ECM-adipocyte metabolic crosstalk are poorly defined. Advanced glycation end-product (AGE) formation is increased in diabetes. AGE alter tissue function via direct effects on ECM and by binding scavenger receptors on multiple cell types and signaling through Rho GTPases. Our goal was to determine the role and underlying mechanisms of AGE in regulating human ECM-adipocyte metabolic crosstalk. Visceral adipocytes from diabetic and non-diabetic humans with obesity were studied in 2D and 3D-ECM culture systems. AGE is increased in adipose tissue from diabetic compared to non-diabetic subjects. Glycated collagen 1 and AGE-modified ECM regulate adipocyte glucose uptake and expression of AGE scavenger receptors and Rho signaling mediators, including the <italic>DIAPH1</italic> gene, which encodes the human Diaphanous 1 protein (hDia1). Notably, inhibition of hDia1, but not scavenger receptors RAGE or CD36, attenuated AGE-ECM inhibition of adipocyte glucose uptake. These data demonstrate that AGE-modification of ECM contributes to adipocyte insulin resistance in human diabetes, and implicate hDia1 as a potential mediator of AGE-ECM-adipocyte metabolic crosstalk.</p>
              </abstract>
              <kwd-group kwd-group-type="npg-subject">
                <title>Subject terms</title>
                <kwd>Mechanisms of disease</kwd>
                <kwd>Type 2 diabetes</kwd>
                <kwd>Metabolic disorders</kwd>
                <kwd>Obesity</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2019</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1" sec-type="introduction">
              <title>Introduction</title>
              <p id="Par2">Adipose tissue metabolic dysfunction underlies the pathogenesis of obesity-associated metabolic disease, including type 2 diabetes (DM), and alterations in the adipose tissue extracellular matrix (ECM) have been implicated<sup><xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR5">5</xref></sup>. Using a novel human ECM-adipocyte co-culture system, we recently demonstrated that adipose tissue ECM regulates adipocyte cellular metabolism in a disease-specific manner, with rescue of cellular insulin resistance in DM adipocytes by non-diabetic (NDM) ECM<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Nonetheless, mechanisms underlying ECM-adipocyte crosstalk and the cascade of events that lead to adipocyte metabolic dysfunction in DM are poorly defined.</p>
              <p id="Par3">Advanced glycation end-products (AGE), the products of nonenzymatic glycation and oxidation of proteins and lipids,<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> are a putative contributor to cellular dysfunction in response to hyperglycemia associated with DM. AGE disrupt protein tertiary structure and alter a wide range of protein functions and structural interactions. AGE also act as ligands for scavenger receptors expressed by many cell types, including Receptor for Advanced Glycation End-products (RAGE) and CD36, triggering multiple signaling pathways with diverse effects on cell function<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. AGE are increased in multiple tissues in DM and contribute to end-organ disease<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR14">14</xref></sup>, but their role in adipose tissue is not well-described. AGE reduce adipogenic differentiation in human mesenchymal cells<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> and impair insulin sensitivity in 3T3-L1 adipocytes cultured in high-glucose-medium<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, suggesting their involvement in adipose tissue insulin resistance. AGE represent a putative mechanism underlying ECM-adipocyte interactions, possibly via signaling through Rho GTPases, a downstream signaling pathway activated by AGE<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Rho GTPases regulate insulin-stimulated glucose uptake in muscle and adipose tissue<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, and AGE activate Rho signaling in endothelial and microglial cells<sup><xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR23">23</xref></sup>, but no published data link AGE and Rho signaling in adipose tissue dysfunction.</p>
              <p id="Par4">The present study evaluates mechanisms by which AGE regulate ECM-adipocyte metabolic crosstalk in human adipose tissue. We hypothesized that AGE-modified ECM impairs adipocyte glucose metabolism via AGE-receptors and Rho signaling. Manipulation of the adipocyte microenvironment was accomplished with high glucose culture of recombinant collagen and ECM. Antagonist antibodies to AGE-receptors and a Rho signaling mediator small molecule inhibitor were used to identify signaling pathways underlying AGE-mediated ECM-adipocyte crosstalk. A 3D human ECM-adipocyte co-culture system was used to simulate the adipose tissue environment <italic>in vitro</italic>. This system provides advantages over other 3D culture methods that use hydrogels or collagens in that it is derived from native adipose tissue and thus provides a more physiologic environment for adipocyte culture.</p>
            </sec>
            <sec id="Sec2" sec-type="results">
              <title>Results</title>
              <sec id="Sec3">
                <title>AGE are increased in adipose tissue of obese diabetic patients</title>
                <p id="Par5">To determine if AGE are increased in adipose tissue in human obesity and DM, we measured AGE levels in subcutaneous (SAT) and visceral (VAT) adipose tissues from obese DM and NDM patients using fluorescence microscopy<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. AGE levels were higher in DM compared to NDM tissues and similar between SAT and VAT (Fig. <xref rid="Fig1" ref-type="fig">1A,B</xref>). Analysis of linear mixed models revealed that VAT and SAT AGE levels correlated directly with percentage of glycated hemoglobin (HbA1c; Fig. <xref rid="Fig1" ref-type="fig">1C,D</xref>). No differences were observed in plasma AGE levels between obese DM and NDM subjects (P = 0.818).<fig id="Fig1"><label>Figure 1</label><caption><p>AGE are increased in diabetic human adipose tissue. (<bold>a</bold>) Representative fluorescence microscopy images and (<bold>b</bold>) quantified mean relative fluorescence intensity units (RFU) of AGE expression in human DM and NDM VAT and SAT. Bars with different letters indicate <italic>P</italic> &lt; 0.050 in multiple comparison analysis. (<bold>c</bold>,<bold>d</bold>) Association of VAT or SAT AGE fluorescence intensity and serum HbA1c percentage for entire cohort. Linear model b value (<bold>b</bold>), standard error (SE) and P-values shown are unadjusted and adjusted for age and sex. VAT: n = 21 NDM, 19 DM subjects; SAT: n = 13 NDM, 12 DM subjects.</p></caption><graphic xlink:href="41598_2019_56242_Fig1_HTML" id="d29e488"/></fig></p>
              </sec>
              <sec id="Sec4">
                <title>Glycated collagen 1 regulates glucose metabolism and Rho-AGE receptor gene expression in adipocytes in 2D culture</title>
                <p id="Par6">We next explored the effects of glycated collagen 1 (GC1) as a surrogate for AGE on adipocyte glucose metabolism and gene expression in 2D culture. Given its stronger association with metabolic disease, for these and all subsequent experiments, we studied adipocytes from VAT. GC1, relative to UCI, had no effect on basal glucose uptake, but decreased insulin-stimulated glucose uptake in DM but not NDM adipocytes (Fig. <xref rid="Fig2" ref-type="fig">2A</xref>). These results suggest that glycated collagen 1 interferes with adipocyte insulin signaling and insulin-stimulated glucose uptake, with the latter effect restricted to DM adipocytes.<fig id="Fig2"><label>Figure 2</label><caption><p>Glycated collagen 1 regulates adipocyte insulin signaling and Rho and AGE scavenger receptor expression. Preadipocytes from human VAT were differentiated into mature adipocytes in 2D culture +/− unglycated or glycated recombinant human collagen 1 (UC1, GC1), then studied with glucose uptake assay or RT-qPCR. (<bold>a</bold>) Glucose uptake in non-stimulated (basal) or insulin-stimulated conditions. Ordinate: mean glucose uptake measured by <sup>3</sup>H-2D-glucose in cell lysates (cpm) normalized to cell lysate protein concentration (mg/ml); bars with different letters indicate P &lt; 0.050; n = 15 NDM, 15 DM subjects. (<bold>b</bold>) Gene expression studied with RT-qPCR. Ordinate: mean fold difference in transcript level in GC1 arm relative to UC1 arm referent = 1; *P &lt; 0.050, comparing transcript levels in GC1 arm vs. UC1 arm; n = 12 NDM, 12 DM subjects.</p></caption><graphic xlink:href="41598_2019_56242_Fig2_HTML" id="d29e514"/></fig></p>
                <p id="Par7">Using real-time quantitative polymerase chain reaction (RT-qPCR), we next evaluated the effects of GC1 on gene expression of <italic>AGER</italic> (Advanced Glycosylation End-Product Specific Receptor, gene designation for RAGE)<italic>, CD36</italic>, and Rho signaling mediators <italic>CDC42</italic> (Cell Division Cycle 42), <italic>DIAPH1</italic> (Rho-dependent Diaphanous Related Formin 1, gene designation for hDia1), <italic>RAC1</italic> (Rac Family Small GTPase 1) and <italic>RHO</italic>A (Ras Homolog Family Member A) in VAT adipocytes from obese DM and NDM subjects. In NDM patients, GC1 decreased expression of <italic>CD36</italic>, <italic>CDC42</italic>, and <italic>RHOA</italic> in NDM compared with UC1 adipocytes, whereas in DM adipocytes, GC1 decreased the expression of <italic>CDC42</italic> and <italic>RAC1</italic> and increased expression of <italic>DIAPH1</italic> (Fig. <xref rid="Fig2" ref-type="fig">2B</xref>). Together, these data suggest that glycated collagen 1 differentially regulates expression of AGE-receptors and Rho signaling mediators in adipocytes from obese DM and NDM subjects, and induces <italic>DIAPH1</italic> expression in a DM-specific manner.</p>
              </sec>
              <sec id="Sec5">
                <title>AGE-modified ECM impairs adipocyte glucose uptake in 3D culture</title>
                <p id="Par8">We next studied the effects of AGE-modified ECM on adipocyte metabolism in a 3D-ECM-adipocyte culture system previously described by our laboratory<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, targeting AGE-modification to the ECM by treating adipose tissue with high glucose concentrations prior to ECM isolation (Fig. <xref rid="Fig3" ref-type="fig">3A</xref>). We first optimized AGE-induction on ECM using high glucose culture by treating adipose tissues for 72 hours with medium containing 17 mM, 50 mM, or 100 mM glucose, or 100 mM mannitol (negative control), prior to isolation of ECM. We also studied ECM isolated from tissues treated with the deglycosylating enzyme PNGase for the final 24 hours of the 72-hour glucose conditioning. Fluorescence microscopy analysis revealed that 100 mM glucose treatment induced AGE on ECM to levels approximating those observed in native DM VAT (Fig. <xref rid="Fig3" ref-type="fig">3B</xref>, compare with Fig. <xref rid="Fig1" ref-type="fig">1B</xref>), while PNGase markedly decreased AGE levels (b = −0.45 ± 0.12; p &lt; 0.001). There was a significant interaction between the PNGase and glycation effect, such that the decrease in the AGE levels on addition of PNGase was significantly higher for the adipocytes in high glucose conditions compared to the decrease observed in low glucose conditions (b = −1.14 ± 0.20; p &lt; 0.001). Based on these results, for all subsequent experiments, we used high glucose (100 mM) treatment to designate AGE-modified ECM and low glucose (17 mM), mannitol (100 mM), and high glucose followed by PNGase treatment as controls.<fig id="Fig3"><label>Figure 3</label><caption><p>AGE-modified adipose tissue ECM regulates adipocyte cellular metabolism. (<bold>a</bold>) Strategy for creation of ECM-adipocyte cultures, including macroscopic photographs and scanning electron micrographs. (<bold>b</bold>) Quantified mean fluorescence of VAT treated with indicated glucose or mannitol concentrations for 72 h, with or without PNGase for final 24 h of treatment. Bars with different letters indicate P &lt; 0.050. (<bold>c</bold>) Basal and insulin-stimulated glucose uptake in preadipocytes from visceral adipose tissue of DM and NDM obese subjects differentiated into mature adipocytes in disease-matched (DM or NDM) ECM prepared from tissues treated with 17 mM (Low) or 100 mM (High) glucose or 100 mM mannitol, +/− PNGase. Ordinates: mean glucose uptake measured by <sup>3</sup>H-2D-glucose in cell lysates (cpm) normalized to cell lysate protein concentration (mg/ml). Bars with different letters indicate P &lt; 0.050; n = 29 NDM, 25 DM subjects.</p></caption><graphic xlink:href="41598_2019_56242_Fig3_HTML" id="d29e599"/></fig></p>
                <p id="Par9">We next evaluated glucose uptake in AGE-modified 3D-ECM-adipocyte culture. ECM isolated from treated VAT was seeded with VAT preadipocytes, combining NDM ECM with NDM preadipocytes, or DM ECM with DM preadipocytes, thus recapitulating diseased (DM) and non-diseased (NDM) tissues. DM ECM-adipocyte cultures treated with low or high glucose manifested decreased basal and insulin-stimulated glucose uptake compared with NDM cultures, confirming the DM-specific defect in glucose uptake previously observed by our laboratory with this 3D ECM-adipocyte system<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. ECM prepared from tissues treated with 100 mM mannitol, in contrast, had no effect on glucose uptake in either NDM or DM ECM-adipocyte cultures. High glucose AGE-modified ECM significantly decreased insulin-stimulated glucose uptake relative to low glucose-conditioned ECM in both NDM and DM ECM-adipocyte cultures but did not affect basal glucose uptake, even after controlling for diabetes status, age and sex. Finally, PNGase treatment of high glucose-treated ECM abrogated its inhibitory effect on insulin-stimulated glucose uptake in NDM and DM ECM-adipocyte cultures after controlling for age and sex (Fig. <xref rid="Fig3" ref-type="fig">3C</xref>). Together these data demonstrate that AGE-modified ECM attenuates adipocyte insulin-stimulated glucose uptake, with this effect being more pronounced in DM ECM-adipocyte cultures.</p>
              </sec>
              <sec id="Sec6">
                <title>AGE-ECM impairment of adipocyte glucose uptake is hDia1-dependent</title>
                <p id="Par10">We next determined the roles of hDia1, RAGE, and CD36 in regulating ECM-adipocyte crosstalk by evaluating glucose uptake in ECM-adipocyte cultures matched by diabetic status treated with antibody directed towards RAGE or CD36, or a small molecule formin homology 2 domain inhibitor (SMIFH2), which inhibits hDia1 function (<bold>refs</bold>). SMIFH2 attenuated AGE-ECM-mediated impairment of insulin sensitivity in NDM and DM ECM-adipocyte cultures as observed by increased glucose uptake (Fig. <xref rid="Fig4" ref-type="fig">4A</xref>). These effect was similarly observed in basal glucose uptake in DM but not in NDM ECM-adipocyte cultures. The improvement of glucose uptake with SMIFH2 was increased in magnitude in high glucose compared to low glucose ECM-adipocyte cultures, and greater in DM compared to NDM cultures. In contrast, RAGE neutralizing antibody, relative to treatment with isotype control antibody, had no effect on glucose uptake in low or high glucose-treated NDM and DM ECM-adipocyte cultures (Fig. <xref rid="Fig4" ref-type="fig">4B</xref>). Similarly, CD36 neutralizing antibody, relative to isotype control antibody, had no effect on glucose uptake in low glucose-treated NDM and DM ECM-adipocyte cultures (Supplemental Fig. <xref rid="MOESM1" ref-type="media">1</xref>). These observations imply that regulation of adipocyte glucose uptake by AGE-modified ECM is partially mediated by hDia1, effects that are more pronounced in the context of increased AGE levels associated with DM and independent of RAGE or CD36.<fig id="Fig4"><label>Figure 4</label><caption><p>hDia1 regulates AGE-mediated ECM-adipocyte metabolic crosstalk in 3D-ECM culture. Preadipocytes were differentiated <italic>in vitro</italic> into mature adipocytes +/− (<bold>a</bold>) the hDia1 small molecule inhibitor SMIFH2 or (<bold>b</bold>) AGE receptor (RAGE) antagonist or isotype control antibodies in disease-matched (NDM or DM) ECM prepared from visceral adipose tissue treated with Low (17 mM) or High (100 mM) glucose, then studied with glucose uptake assay without (basal) or with insulin stimulation. Ordinates: mean <sup>3</sup>H-2D-glucose uptake (cpm) normalized to cell lysate protein concentration (mg/ml). Bars with different letters indicate P &lt; 0.050; n = 22 NDM,16 DM subjects. (<bold>c</bold>) A simplified model for AGE regulation of adipocyte glucose uptake.</p></caption><graphic xlink:href="41598_2019_56242_Fig4_HTML" id="d29e649"/></fig></p>
              </sec>
            </sec>
            <sec id="Sec7" sec-type="discussion">
              <title>Discussion</title>
              <p id="Par11">The role of AGE in regulating adipose tissue dysfunction in the context of DM remains poorly understood. AGE are increased in kidney, muscle, skin, and liver in obese DM humans<sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref></sup>, and in adipose tissue in obese rodents<sup><xref ref-type="bibr" rid="CR13">13</xref></sup> but study of AGE in human adipose tissue is sparse. A single report demonstrates increased AGE levels in SAT in obese compared to lean humans<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, with no published reports of AGE levels in human VAT. We demonstrate that elevated AGE levels in VAT and SAT is a feature of human obesity-associated DM. In contrast, we observed no correlation between plasma AGE levels and obesity or DM. Some prior studies demonstrate decreased plasma AGE levels in obesity<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>, while others show the opposite<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Different patient populations and detection assays may account for these conflicting data. Of note, decreased AGE plasma levels have been associated with increased adipose tissue AGE levels<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, suggesting that tissues may act as an ‘AGE-sink’, reducing plasma levels. Our data are consistent with these data in that they support that plasma AGE levels do not accurately reflect tissue levels in human metabolic disease.</p>
              <p id="Par12">We demonstrate that in 2D-culture, GC1 attenuates adipocyte glucose uptake in DM adipocytes, consistent with prior studies demonstrating a similar effect of glycated albumin or high glucose in 3T3L1 adipocytes<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR31">31</xref></sup>. We observed distinct effects of GC1 on adipocyte glucose metabolism depending on DM status, suggesting disease-specific effects of AGE-modified collagen on cellular metabolism. The detrimental effects of GC1 on DM but not NDM adipocytes suggest that intrinsic cellular defects associated with metabolic disease render adipocytes susceptible to metabolic impairment by glycated collagen.</p>
              <p id="Par13">To better model the complexity of native adipose tissue, we used a 3D-ECM-adipocyte culture system that permits isolated manipulation of ECM. Using this system, we observed an inhibitory effect of AGE-modified ECM on adipocyte glucose uptake that was reversed with PNGase treatment, suggesting that glycated ECM contributes to the well-established state of adipocyte cellular insulin resistance associated with DM<sup><xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR34">34</xref></sup>. In addition, the effects of AGE-modified ECM on glucose uptake were more profound than those of GC1 in 2D culture, suggesting that glycation of ECM proteins in addition to collagen 1 are required for maximal effects of AGE on adipocyte metabolism, and likely involve multiple AGE moieties on multiple ECM proteins. Notably, the effect of AGE-modified ECM on adipocyte glucose metabolism was greater in DM compared to NDM ECM-adipocyte cultures, and furthermore, PNGase treatment of AGE-modified ECM increased adipocyte glucose uptake to levels higher than in non-AGE modified ECM not treated with PNGase in both NDM and DM cultures. These observations suggest that a degree of pre-existing glycosylation carried over from the <italic>in vivo</italic> environment present on both obese DM and NDM ECM already impairs adipocyte metabolism, that further <italic>in vitro</italic> AGE induction on ECM has additional detrimental effects on adipocyte glucose uptake, and finally, that complete <italic>in vitro</italic> removal of ECM glycosylation improves adipocyte glucose uptake to levels beyond that observed in untreated ECM.</p>
              <p id="Par14">AGE mediate their effects in part by binding scavenger receptors on a wide range of cells and triggering downstream signaling pathways. Dominant among these scavenger receptors is RAGE, activation of which induces cellular and systemic insulin resistance in multiple models<sup><xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref></sup>. RAGE expression in epicardial adipose tissue correlates directly with epicardial fat thickness and indirectly with GLUT4 expression<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, while RAGE expression in SAT correlates indirectly with coronary artery disease<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. AGE also signal through the scavenger receptor CD36; the role of CD36 in metabolic disease is controversial, with some data demonstrating beneficial cellular and systemic metabolic effects, while other data demonstrate the opposite<sup><xref ref-type="bibr" rid="CR40">40</xref>–<xref ref-type="bibr" rid="CR42">42</xref></sup>. We observed no significant effect of GC1 on <italic>AGER</italic> expression, decreased CD36 transcript levels in response to GC1 in NDM adipocytes, and finally, no effect of antibody-inhibition of RAGE or CD36 on glucose uptake in adipocytes cultured in AGE-modified ECM. These observations suggest that AGE-ECM exerts its effects on adipocyte insulin resistance independent of RAGE and CD36; the observed downregulation of CD36 by GC1 in NDM adipocytes suggests that this receptor may mediate cellular responses to AGE distinct from insulin resistance; further research will be necessary to explore this hypothesis.</p>
              <p id="Par15">Data regarding the role of Rho GTPases in regulating cellular and systemic metabolism are conflicting. The Rho signaling family is comprised of many mediators with complex tissue- and context-specific functions, precluding broad generalizations. Rac1, for example, potentiates skeletal muscle glucose uptake via regulation of cytoskeletal mobilization of GLUT4 transporters<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>, but does not appear to play a similar role in adipocytes<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>. In contrast, RhoA and ROCK promote insulin resistance in myocytes<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> and pancreatic beta cells<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Other data demonstrate that Rho signaling is upregulated in adipose and other tissues in murine and human obesity<sup><xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR51">51</xref></sup>, and that Rho inhibition improves systemic metabolism<sup><xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR54">54</xref></sup>. Together, these observations suggest both positive and negative effects of Rho signaling on cellular and systemic metabolism. The mammalian Diaphanous-related formin protein family are Rho GTPase effectors that mediate actin polymerization and microtubule stabilization. Human Diaphanous 1 (hDia1) and its murine homolog mDia1, is the best studied of the Dia family, and mediates cell migration via AGE/RAGE signaling in non-adipocyte cell types<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup>. Few data describe the role of hDia1 in adipocytes, with a single report demonstrating that mDia1 regulates adipogenic differentiation of murine mesenchymal stem cells<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. We demonstrate increased <italic>DIAPH1</italic> transcript levels in DM but not NDM adipocytes in response to GC1. Furthermore, we observed that treatment with SMIFH2 attenuated AGE-ECM-induced inhibition of insulin-stimulated glucose uptake in NDM and DM ECM-adipocyte cultures, suggesting a role for hDia1 in promoting cellular insulin resistance in adipocytes in response to AGE. These observations, along with prior data linking adipose tissue Rho activity to insulin resistance<sup><xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR51">51</xref></sup>, suggest that DM adipocytes may be more susceptible than NDM adipocytes to increased hDia1 expression in response to AGE, contributing to cellular insulin resistance in DM. Consistent with this hypothesis is the observed increased in <italic>DIAPH1</italic> transcript levels in response to GC1 in DM but not NDM adipocytes.</p>
              <p id="Par16">We studied VAT given its stronger association with metabolic disease, and due to limitations in access to SAT. DM subjects were older, included more men, and had a higher prevalence of other metabolic diseases than NDM subjects; we adjusted post-hoc for age, sex, and BMI in comparisons between NDM and DM groups, and comparisons between AGE-treated and non-AGE-treated arms were matched for each subject as paired analyses, and thus internally controlled. Nonetheless, larger studies will be required to rigorously address the role of age, sex, medication use, and other clinical variables in contributing to DM-specific differences in ECM-adipocyte crosstalk. PNGase F is known to be specific for N-glycans, but our data suggest that it removes AGE moieties as well, at least as measured by fluorescence. It is possible that PNGase F may have broader specificity than currently understood, or alternatively, we may have observed removal of AGE-modified N-glycans by PNGase F. Future detailed studies using mass spectrometry and other biochemical approaches will be required to answer these questions. We studied the effects of glycated collagen on adipocytes by adding soluble glycated collagen directly to the culture media, but study of collagen-coated culture plates may provide different results, which will be addressed in future research. <italic>In vitro</italic> high glucose conditioning is not a perfect model for AGE-induction, likely inducing different profiles of AGE moieties than those present <italic>in vivo</italic>. Nonetheless, this is an accepted method of AGE induction, and in our model system, achieved AGE levels similar to those observed in DM adipose tissues. Future research will study alternative AGE-induction methods, including ribose- or glyoxalate-conditioning<sup><xref ref-type="bibr" rid="CR58">58</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup>. Finally, while frequently used as an inhibitor of hDia1<sup><xref ref-type="bibr" rid="CR60">60</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup>, SMIFH2 also inhibits other formin-domain-containing proteins, which may regulate AGE effects on adipocyte metabolism. Future experiments studying targeted knockdown of hDia using shRNA will clarify this issue, methodology which to date has not been feasible in 3D-ECM-adipocyte culture.</p>
              <p id="Par17">We demonstrate that AGE mediate ECM-adipocyte metabolic crosstalk in human adipocytes, possibly via regulation of the Rho signaling mediator hDia1. These data implicate AGE-modified adipose tissue ECM and Rho signaling as contributing mechanisms to adipocyte metabolic dysfunction in DM.</p>
            </sec>
            <sec id="Sec8">
              <title>Methods</title>
              <sec id="Sec9">
                <title>Human subjects</title>
                <p id="Par18">All human subjects underwent informed consent for study participation and were enrolled with Institutional Review Board approval at University of Michigan and Ann Arbor Veterans Affairs Healthcare System. Patient enrollment and all methods were performed in accordance with all methods were performed in accordance with all relevant institutional, federal, and international guidelines and regulations. VAT from the greater omentum, SAT from the abdominal wall, and peripheral blood were collected from obese subjects during bariatric surgery (Table <xref rid="Tab1" ref-type="table">1</xref>). Due to limitations in tissue amounts, tissue and cell samples subsets of a total of 165 subjects were used for each experiment, with numbers of subjects for each experiment reported in figure legends. DM subjects were defined by clinical diagnosis requiring medication and hemoglobinA1c (HbA1c) &gt;= 6.5%. Non-diabetic (NDM) subjects were defined by no clinical history of diabetes and HbA1c &lt;5.7% per American Diabetes Association criteria<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Subject demographics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>DM (n = 75)</th><th>NDM (n = 90)</th><th>P-value*</th></tr></thead><tbody><tr><td colspan="4"><bold><underline>Clinical characteristics</underline></bold></td></tr><tr><td>Sex (% male)</td><td>61%</td><td>51%</td><td>0.019</td></tr><tr><td>Age (mean, SD, years)</td><td>55 (11)</td><td>44 (11)</td><td>&lt;0.001</td></tr><tr><td>BMI (mean, SD, kg/m<sup>2</sup>)</td><td>44 (6)</td><td>46 (6)</td><td>0.346</td></tr><tr><td>HbA1c (mean, SD, %)</td><td>7.1% (1.0%)(1.0%)</td><td>5.4% (0.3%)</td><td>&lt;0.001</td></tr><tr><td colspan="4"><bold><underline>Comorbid diseases (%)</underline></bold></td></tr><tr><td>Sleep apnea</td><td>85%</td><td>67%</td><td>0.383</td></tr><tr><td>Hypertension</td><td>70%</td><td>41%</td><td>&lt;0.001</td></tr><tr><td>Dyslipidemia</td><td>72%</td><td>23%</td><td>&lt;0.001</td></tr><tr><td colspan="4"><bold><underline>Medications (%)</underline></bold></td></tr><tr><td>ACE inhibitor</td><td>42%</td><td>12%</td><td>&lt;0.001</td></tr><tr><td>β-blocker</td><td>29%</td><td>12%</td><td>0.025</td></tr><tr><td>Insulin</td><td>42%</td><td>0%</td><td>&lt;0.001</td></tr><tr><td>Metformin</td><td>75%</td><td>4%</td><td>&lt;0.001</td></tr><tr><td>Statin</td><td>67%</td><td>19%</td><td>&lt;0.001</td></tr><tr><td>Sulfonylurea</td><td>20%</td><td>0%</td><td>&lt;0.001</td></tr><tr><td>Thiazolidinedione</td><td>4%</td><td>0%</td><td>0.076</td></tr><tr><td>GLP-1 modulator</td><td>4%</td><td>0%</td><td>0.041</td></tr></tbody></table><table-wrap-foot><p>*Independent t-test and Fisher’s exact test were used to compare continuous and dichotomous variables respectively between DM and NDM groups; SD: standard deviation.</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec10">
                <title>Fluorescence microscopy</title>
                <p id="Par19">AGE levels in adipose tissue and plasma were quantified using fluorescence microscopy based on AGE autofluorescence<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. Adipose tissue was frozen in liquid nitrogen, embedded in optimal cutting temperature compound, sectioned (100 μm) on a Microm HM500OM cryostat (GMI Inc., Ramsey, MN, USA), and imaged on an Olympus IX-81 fluorescent microscope using 10X objective, excitation 377 nm +/− 25nm, emission 447 nm +/− 30nm. Four grayscale TIFF images were captured for each slide, 9.6 ms exposure, ISO 200. Pixel intensities were measured with ImageJ software. For plasma, 5 μl of plasma was spotted on a glass slide, dried, then imaged with identical technique except 8.78 ms exposure.</p>
              </sec>
              <sec id="Sec11">
                <title>Adipose tissue ECM isolation</title>
                <p id="Par20">Adipose tissue ECM isolation was performed as described<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, based on modifications of published protocols<sup><xref ref-type="bibr" rid="CR63">63</xref>–<xref ref-type="bibr" rid="CR65">65</xref></sup>. VAT explants were freeze-thawed from −80 °C, 20 min to 37 °C three times in 10 mM Tris, 5 mM EDTA, 1% phenylmethanesulphonylfluoride (PMSF), pH8.0, then incubated 37 °C, 24hrs in 0.25% Trypsin/0.1%EDTA; then washed in rinsing buffer (8 g/L NaCl, 200 mg/L KCl, 1 g/L Na2HPO4, 200 mg/L KH2PO4, 1% PMSF), 37° C, 20 min three times; then incubated 37° C, 24hrs in 55 mM Na2HPO4, 17 mM KH2PO4, 4.9 mM MgSO4*7H2O, 160 U/mL DNase I type II, 100 μg/mL RNase type IIIA, 80 U/mL lipase type VI-S (Sigma-Aldrich Inc., St. Louis MO, USA), 1% PMSF; then washed sequentially in rinsing buffer 37 °C, 20 min three times; 99.9% isopropanol, 1% PMSF 25 °C once for 24hrs; then washed in rinsing buffer 37 °C, 20 min three times; then washed in 70% EtOH, 37 °C, 20 min 3X three times; then washed in storage solution (PBS, 1% PMSF) 37 °C, 20 min once; then stored in storage solution 4 °C until use.</p>
                <p id="Par21">To prepare AGE-modified ECM, 200 mg VAT explants were cultured 72 hours, 37 °C in maintenance medium containing either 17 mM (Low glucose), 50 mM, or 100 mM (High glucose) glucose, or 100 mM mannitol, doses based on prior literature<sup><xref ref-type="bibr" rid="CR59">59</xref>,<xref ref-type="bibr" rid="CR66">66</xref>,<xref ref-type="bibr" rid="CR67">67</xref></sup> and dose-response experiments demonstrating that 100 mM glucose generated levels of AGE-modification similar to native DM adipose tissue (Fig. <xref rid="Fig3" ref-type="fig">3B</xref>). The deglycosylating enzyme PNGase-F, was added for the final 24 hours of 72-hour treatment (2.5 units/mL, Sigma-Aldrich Inc., St Louis, MO, USA, Cat#F8435-300UN). ECM was then prepared from treated tissues as described above.</p>
              </sec>
              <sec id="Sec12">
                <title>Scanning electron microscopy (SEM)</title>
                <p id="Par22">SEM was performed as described<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Briefly, tissues were fixed, mounted on SEM-stub with colloidal graphite, sputter-coated with gold, and images captured on an Amray 1910 scanning electron microscope.</p>
              </sec>
              <sec id="Sec13">
                <title>2D adipocyte culture</title>
                <p id="Par23">2D-adipocyte culture was performed as described<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup>. Briefly, adipose tissue was digested with Type II collagenase (2 mg/mL in PBS/2% BSA, Life Technologies Inc., Carlsbad, CA, USA) 37 °C, 60 min, centrifuged 250rcf, the stromal-vascular cell pellet retrieved, plated overnight, and adherent cells passaged 3X to enrich for preadipocytes, which were frozen in DMEM/F12, 15% fetal calf serum (FCS), 10% DMSO in liquid nitrogen until use. To generate mature adipocytes for 2D culture, preadipocytes (60,000 cells/well in 24-well plates) were plated in DMEM/F12, 15% FCS until confluent, cultured 7days in differentiation medium (DMEM/F12, 2.5 mM glutamine, 15 mM HEPES, 10 mg/ml transferrin, 33 μM biotin, 0.5 μM human insulin, 17 μM pantothenate, 0.1 μM dexamethasone, 2 nM T3, 540 μM IBMX, 1 μM ciglitazone), then cultured 7days in maintenance medium (DMEM/F12, 2.5 mM glutamine, 15 mM HEPES, 10 mg/ml transferrin, 33 μM biotin, 0.5 μM human insulin) until differentiated.</p>
                <p id="Par24">Unglycated or glycated recombinant human collagen 1 was added to culture media in soluble form for 2D culture. For glycation, recombinant human collagen 1 (Rockland Immunochemicals, Inc., Limerick, PA, USA, Cat#009-001-103) was incubated in 100 μg/ml with 500 mM D-glucose-6-phosphate in PBS, 4 weeks, 37 °C, and used at 20 μg/ml in culture, based on previously published methods<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>, as well as dose response studies we performed studying concentrations ranging from 20–100 μg/ml that demonstrated 20 μg/ml provided maximal effect on adipocyte glucose uptake.</p>
              </sec>
              <sec id="Sec14">
                <title>3D adipocyte culture</title>
                <p id="Par25">3D-adipocyte culture was performed as described<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup>. Decellularized human VAT ECM was rinsed in 70% EtOH, rehydrated in PBS, cut into 200 mg fragments, seeded with 60,000 preadipocytes in 20 μL of complete growth medium (DMEM, 10% FCS), incubated 37 °C, 5%CO<sub>2</sub>, 40 min to allow cells to adhere, then 0.5 mL of complete growth medium added, incubated 37 °C, 5%CO<sub>2</sub>, 24hrs, transferred to a fresh culture plate, 0.5 mL of complete growth medium added, cultured 3 days, then cultured in 0.5 mL differentiation medium 14 days to generate mature adipocytes in ECM.</p>
                <p id="Par26">RAGE neutralizing antibody (IgG2b mu-α-huRAGE) and IgG2b mu-α-hu isotype control antibody (Abcam Inc., Cambridge, MA, USA, Cat#ab89911, Cat#ab170192 respectively, 2 μg/mL) or CD36 neutralizing antibody (IgA mu-α-huCD36) and IgA mu-α-hu isotype control antibody (Abcam Inc., Cambridge, MA, USA, Cat#ab23680, Novus Biologicals, Centennial, CO, USA, Cat# NBP1-97030 respectively, 2 μg/mL) were added to ECM-adipocyte cultures throughout adipocyte differentiation and during glucose uptake assay; the hDia1 small molecule formin FH2-domain inhibitor SMIFH2<sup><xref ref-type="bibr" rid="CR60">60</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup> (25 μM, Sigma-Aldrich Inc., St. Louis, MO, USA, Cat#344092) was used for 20 minutes prior to and throughout glucose uptake assay.</p>
              </sec>
              <sec id="Sec15">
                <title>Metabolic phenotyping</title>
                <p id="Par27">For glucose uptake assay, adipocytes in 2D-culture or 3D-ECM were cultured 37 °C, 72hrs in 0.5 mL maintenance medium; then in serum-free DMEM:F12, 37 °C, 12hrs; in PBS/1% BSA, 37 °C, 2hrs; washed in PBS, then cultured in 0.5 mL PBS +/−100 nM human insulin, 37 °C, 40 min; in 0.5 mL PBS +/− 200 nM insulin, 0.1 mM 2-deoxy glucose, 2 μCi/mL deoxy-D-glucose-2-[1,2-<sup>3</sup> H(N)] (PerkinElmer Inc., Waltham, MA, USA) 37 °C, 40 min, then washed with PBS, and 420 μL 1% SDS solution added, and cells lysed with pipetting. 10 μL of cell lysate was used for Bradford protein assay; 400 μL of lysate was transferred to 2 mL scintillation fluid and counts per minute (cpm) measured on a scintillation counter and normalized to cell lysate protein concentration.</p>
              </sec>
              <sec id="Sec16">
                <title>RT-qPCR</title>
                <p id="Par28">Adipocytes were lysed in Trizol and RNA extracted with RNAEasy Fibrous Tissue MiniKit (Qiagen Inc., Hilden, Germany). Purity, concentration, and integrity of mRNA were evaluated using a NanoDrop 1000 spectrophotometer (Thermo Scientific, Wilmington, DE, USA). Equal amounts of input RNA were reverse-transcribed using the Applied Biosystems High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA). RT-qPCR was conducted with TaqMan primers and reagents (Life Technologies Inc., Carlsbad, CA, USA). Data are presented as fold changes calculated from least squares mean differences according to the 2<sup>−ΔΔCt</sup> method<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> and normalized to the mean of <italic>B2M</italic> and <italic>GAPDH</italic> housekeeping gene controls, for which Ct values did not change with GC1 treatment.</p>
              </sec>
              <sec id="Sec17">
                <title>Statistics</title>
                <p id="Par29">Statistical analysis was performed in STATA-version 15 (StataCorp LLC, College Station, TX, USA). Data was tested for normality and homoscedasticity and analyzed accordingly. The a-priori α-level was set at 5%. Means and standard errors of measures are displayed in figures. Linear mixed model was used to compare AGE-immunofluorescence in tissues by diabetes status, using an interaction term between diabetes status and depot to assess if differences between DM and NDM tissues were affected by depot. The relationship between AGE-immunofluorescence and HbA1c was estimated using linear mixed model in VAT and SAT separately (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). In 2D-culture experiments, linear mixed model was used to detect differences in log-transformed glucose uptake by treatment (UC1, GC1) and diabetes status. An interaction term for treatment and diabetes status was used to assess if the effect of treatment on glucose uptake was different for DM and NDM patients. For RT-qPCR data, dCT values between experimental arms were compared using two-way ANOVA mixed model (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). For 3D-culture experiments (Figs. <xref rid="Fig3" ref-type="fig">3</xref>, <xref rid="Fig4" ref-type="fig">4</xref>), linear mixed models were used to estimate the effect of different levels of ECM glycation (mannitol, low glucose, medium glucose, high glucose, PNGase as applicable), diabetes status, RAGE antibody, and SMIFH2, and interactions between these factors, on glucose uptake. Random intercept was used for all models to account for within-subject correlations, while controlling for age, sex, and BMI of both adipocyte and ECM patient source. Post-hoc pairwise comparisons were performed to detect differences in outcome variables at different levels of independent variables using Bonferroni’s correction for multiple testing. Figures present data as means with standard errors of mean.</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary information</title>
              <sec id="Sec18">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="41598_2019_56242_MOESM1_ESM.pdf">
                      <caption>
                        <p>Supplementary Figure 1</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <sec>
              <title>Supplementary information</title>
              <p>is available for this paper at 10.1038/s41598-019-56242-z.</p>
            </sec>
            <ack>
              <title>Acknowledgements</title>
              <p>We thank Danielle Berger NP, Terra Babas MA, Christine Bridge MA, Simone Correa MA, Retha Geiss MA, Jennifer Lavey, Andrew Schlaud, MA, and Marilyn Woodruff NP for assistance with study coordination; SEM was performed by University of Michigan Microscopy &amp; Image Analysis Laboratory Biomedical Research Core Facility. This project was supported by NIH grants R01DK097449 (RWO), R01DK115190 (RWO, CNL), R01DK090262 (CNL), Veterans Affairs Merit Review Award I01CX001811 from the U.S. Department of Veterans Affairs Clinical Sciences Research and Development Service (RWO), Pilot and Feasibility Grant from the Michigan Diabetes Research Center (NIH Grant P30-DK020572) (RWO), Veterans Administration VISN 10 SPARK Pilot Grant (RWO).</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Author contributions</title>
              <p>Conception and design of research: C.S.B., C.N.L., R.W.O.; performed experiments: C.S.B., N.A.B., C.G.F., C.K.N., D.P.; analyzed data: C.S.B., M.K., C.N.L., R.W.O.; interpreted results: C.S.B., N.A.B., C.G.F., J.B.D., J.F.F., A.A.G., O.A.V., C.N.L., R.W.O.; prepared figures: C.S.B., R.W.O.; drafted manuscript: C.S.B., R.W.O.; all authors edited and revised manuscript drafts and approved final version of manuscript.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data availability</title>
              <p>All data generated and analyzed for this study are included in the published article and Supplementary Information Files. All reagents will be freely provided upon reasonable request, except for human tissue and cell samples, and human subject clinical information or identifying information, which are not permitted to be shared due to IRB, HIPAA, and confidentiality constraints.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Competing interests</title>
              <p id="Par30">The authors declare no competing interests.</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lackey</surname>
                      <given-names>DE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2013</year>
                  <volume>306</volume>
                  <fpage>E233</fpage>
                  <lpage>E246</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00476.2013</pub-id>
                  <?supplied-pmid 24302007?>
                  <pub-id pub-id-type="pmid">24302007</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sun</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction</article-title>
                  <source>Nat. Commun.</source>
                  <year>2014</year>
                  <volume>5</volume>
                  <fpage>3485</fpage>
                  <pub-id pub-id-type="doi">10.1038/ncomms4485</pub-id>
                  <?supplied-pmid 24647224?>
                  <pub-id pub-id-type="pmid">24647224</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Muir</surname>
                      <given-names>LA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity</article-title>
                  <source>Obesity</source>
                  <year>2016</year>
                  <volume>24</volume>
                  <fpage>597</fpage>
                  <lpage>605</lpage>
                  <pub-id pub-id-type="doi">10.1002/oby.21377</pub-id>
                  <?supplied-pmid 26916240?>
                  <pub-id pub-id-type="pmid">26916240</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Divoux</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss</article-title>
                  <source>Diabetes</source>
                  <year>2010</year>
                  <volume>59</volume>
                  <fpage>2817</fpage>
                  <lpage>2825</lpage>
                  <pub-id pub-id-type="doi">10.2337/db10-0585</pub-id>
                  <?supplied-pmid 20713683?>
                  <pub-id pub-id-type="pmid">20713683</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spencer</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2010</year>
                  <volume>299</volume>
                  <fpage>E1016</fpage>
                  <lpage>E1027</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00329.2010</pub-id>
                  <?supplied-pmid 20841504?>
                  <pub-id pub-id-type="pmid">20841504</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baker</surname>
                      <given-names>NA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Diabetes-Specific Regulation of Adipocyte Metabolism by the Adipose Tissue Extracellular Matrix</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2017</year>
                  <volume>102</volume>
                  <fpage>1032</fpage>
                  <lpage>1043</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2016-2915</pub-id>
                  <?supplied-pmid 28359093?>
                  <pub-id pub-id-type="pmid">28359093</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Thornalley</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Advanced glycation endproducts: what is their relevance to diabetic complications?</article-title>
                  <source>Diabetes Obes. Metab.</source>
                  <year>2007</year>
                  <volume>9</volume>
                  <fpage>233</fpage>
                  <lpage>245</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1463-1326.2006.00595.x</pub-id>
                  <?supplied-pmid 17391149?>
                  <pub-id pub-id-type="pmid">17391149</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ott</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Role of advanced glycation end products in cellular signaling</article-title>
                  <source>Redox Biol.</source>
                  <year>2014</year>
                  <volume>2</volume>
                  <fpage>411</fpage>
                  <lpage>429</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.redox.2013.12.016</pub-id>
                  <?supplied-pmid 24624331?>
                  <pub-id pub-id-type="pmid">24624331</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shekhtman</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ramasamy</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>AM</given-names>
                    </name>
                  </person-group>
                  <article-title>Glycation &amp; the RAGE axis: targeting signal transduction through DIAPH1</article-title>
                  <source>Expert. Rev. Proteomics</source>
                  <year>2017</year>
                  <volume>14</volume>
                  <fpage>147</fpage>
                  <lpage>156</lpage>
                  <pub-id pub-id-type="doi">10.1080/14789450.2017.1271719</pub-id>
                  <?supplied-pmid 27967251?>
                  <pub-id pub-id-type="pmid">27967251</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gaens</surname>
                      <given-names>KH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Endogenous formation of Nε-(carboxymethyl) lysine is increased in fatty livers and induces inflammatory markers in an <italic>in vitro</italic> model of hepatic steatosis</article-title>
                  <source>J. Hepatol.</source>
                  <year>2012</year>
                  <volume>56</volume>
                  <fpage>647</fpage>
                  <lpage>655</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jhep.2011.07.028</pub-id>
                  <?supplied-pmid 21907687?>
                  <pub-id pub-id-type="pmid">21907687</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>de la Maza</surname>
                      <given-names>MP</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Weight increase is associated with skeletal muscle immunostaining for advanced glycation end products, receptor for advanced glycation end products, and oxidation injury</article-title>
                  <source>Rejuvenation Res.</source>
                  <year>2008</year>
                  <volume>11</volume>
                  <fpage>1041</fpage>
                  <lpage>1048</lpage>
                  <pub-id pub-id-type="doi">10.1089/rej.2008.0786</pub-id>
                  <?supplied-pmid 19086911?>
                  <pub-id pub-id-type="pmid">19086911</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy</article-title>
                  <source>Intern. Med.</source>
                  <year>2006</year>
                  <volume>45</volume>
                  <fpage>435</fpage>
                  <lpage>441</lpage>
                  <pub-id pub-id-type="doi">10.2169/internalmedicine.45.1557</pub-id>
                  <?supplied-pmid 16679697?>
                  <pub-id pub-id-type="pmid">16679697</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Genuth</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes</article-title>
                  <source>Diabetes</source>
                  <year>2005</year>
                  <volume>54</volume>
                  <fpage>3103</fpage>
                  <lpage>3111</lpage>
                  <pub-id pub-id-type="doi">10.2337/diabetes.54.11.3103</pub-id>
                  <?supplied-pmid 16249432?>
                  <pub-id pub-id-type="pmid">16249432</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Curtis</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Stitt</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Advanced glycation end products and diabetic retinopathy</article-title>
                  <source>Curr. Med. Chem.</source>
                  <year>2013</year>
                  <volume>20</volume>
                  <fpage>3234</fpage>
                  <lpage>3240</lpage>
                  <pub-id pub-id-type="doi">10.2174/09298673113209990025</pub-id>
                  <?supplied-pmid 23745547?>
                  <pub-id pub-id-type="pmid">23745547</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kume</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Advanced glycation end‐products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>2005</year>
                  <volume>20</volume>
                  <fpage>1647</fpage>
                  <lpage>1658</lpage>
                  <pub-id pub-id-type="doi">10.1359/JBMR.050514</pub-id>
                  <?supplied-pmid 16059636?>
                  <pub-id pub-id-type="pmid">16059636</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Unoki</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes</article-title>
                  <source>Diabetes Res. Clin. Pract.</source>
                  <year>2007</year>
                  <volume>76</volume>
                  <fpage>236</fpage>
                  <lpage>244</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.diabres.2006.09.016</pub-id>
                  <?supplied-pmid 17097186?>
                  <pub-id pub-id-type="pmid">17097186</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ramasamy</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Yan</surname>
                      <given-names>SF</given-names>
                    </name>
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>AM</given-names>
                    </name>
                  </person-group>
                  <article-title>RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts</article-title>
                  <source>J. Leukoc. Biol.</source>
                  <year>2009</year>
                  <volume>86</volume>
                  <fpage>505</fpage>
                  <lpage>512</lpage>
                  <pub-id pub-id-type="doi">10.1189/jlb.0409230</pub-id>
                  <?supplied-pmid 19477910?>
                  <pub-id pub-id-type="pmid">19477910</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Satoh</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Rho GTPases in insulin-stimulated glucose uptake</article-title>
                  <source>Small GTPases</source>
                  <year>2014</year>
                  <volume>5</volume>
                  <fpage>e28102</fpage>
                  <pub-id pub-id-type="doi">10.4161/sgtp.28102</pub-id>
                  <?supplied-pmid 24613967?>
                  <pub-id pub-id-type="pmid">24613967</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway</article-title>
                  <source>J. Neuroimmunol.</source>
                  <year>2017</year>
                  <volume>305</volume>
                  <fpage>108</fpage>
                  <lpage>114</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jneuroim.2017.02.010</pub-id>
                  <?supplied-pmid 28284330?>
                  <pub-id pub-id-type="pmid">28284330</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hirose</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Tanikawa</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Mori</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Okada</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Tanaka</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway</article-title>
                  <source>FEBS Lett.</source>
                  <year>2010</year>
                  <volume>584</volume>
                  <fpage>61</fpage>
                  <lpage>66</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.febslet.2009.11.082</pub-id>
                  <?supplied-pmid 19944695?>
                  <pub-id pub-id-type="pmid">19944695</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lu</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The Rho/Rho-associated protein kinase inhibitor fasudil in the protection of endothelial cells against advanced glycation end products through the nuclear factor κB pathway</article-title>
                  <source>Exp. Ther. Med.</source>
                  <year>2013</year>
                  <volume>6</volume>
                  <fpage>310</fpage>
                  <lpage>316</lpage>
                  <pub-id pub-id-type="doi">10.3892/etm.2013.1125</pub-id>
                  <?supplied-pmid 24137180?>
                  <pub-id pub-id-type="pmid">24137180</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>Xd</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Advanced Glycation End Products Activate the mi RNA/RhoA/ROCK 2 Pathway in Endothelial Cells</article-title>
                  <source>Microcirculation</source>
                  <year>2014</year>
                  <volume>21</volume>
                  <fpage>178</fpage>
                  <lpage>186</lpage>
                  <pub-id pub-id-type="doi">10.1111/micc.12104</pub-id>
                  <?supplied-pmid 25279428?>
                  <pub-id pub-id-type="pmid">25279428</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhou</surname>
                      <given-names>X</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mdia1 is crucial for advanced glycation end product-induced endothelial hyperpermeability</article-title>
                  <source>Cell. Physiol. Biochem.</source>
                  <year>2018</year>
                  <volume>45</volume>
                  <fpage>1717</fpage>
                  <lpage>1730</lpage>
                  <pub-id pub-id-type="doi">10.1159/000487780</pub-id>
                  <?supplied-pmid 29490301?>
                  <pub-id pub-id-type="pmid">29490301</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dong</surname>
                      <given-names>XN</given-names>
                    </name>
                    <name>
                      <surname>Qin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>XJB</given-names>
                    </name>
                  </person-group>
                  <article-title><italic>In situ</italic> accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption</article-title>
                  <source>Bone</source>
                  <year>2011</year>
                  <volume>49</volume>
                  <fpage>174</fpage>
                  <lpage>183</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bone.2011.04.009</pub-id>
                  <?supplied-pmid 21530698?>
                  <pub-id pub-id-type="pmid">21530698</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thomas</surname>
                      <given-names>MC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The relationship between levels of advanced glycation end-products and their soluble receptor and adverse outcomes in adults with type 2 diabetes</article-title>
                  <source>Diabetes Care</source>
                  <year>2015</year>
                  <volume>38</volume>
                  <fpage>dc150925</fpage>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gaens</surname>
                      <given-names>KH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Nε-(carboxymethyl) lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance</article-title>
                  <source>Arterioscler. Thromb. Vasc. Biol.</source>
                  <year>2014</year>
                  <volume>34</volume>
                  <fpage>1199</fpage>
                  <lpage>1208</lpage>
                  <pub-id pub-id-type="doi">10.1161/ATVBAHA.113.302281</pub-id>
                  <?supplied-pmid 24723555?>
                  <pub-id pub-id-type="pmid">24723555</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Semba</surname>
                      <given-names>RD</given-names>
                    </name>
                    <name>
                      <surname>Arab</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Nicklett</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Ferrucci</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Fat Mass Is Inversely Associated with Serum Carboxymethyl-Lysine, An Advanced Glycation End Product, in Adults, 2</article-title>
                  <source>J. Nutr.</source>
                  <year>2011</year>
                  <volume>141</volume>
                  <fpage>1726</fpage>
                  <lpage>1730</lpage>
                  <pub-id pub-id-type="doi">10.3945/jn.111.143172</pub-id>
                  <?supplied-pmid 21775524?>
                  <pub-id pub-id-type="pmid">21775524</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Uribarri</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?</article-title>
                  <source>J. Clin.l Endocrinol. Metabolis</source>
                  <year>2015</year>
                  <volume>100</volume>
                  <fpage>1957</fpage>
                  <lpage>1966</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2014-3925</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chang</surname>
                      <given-names>C-C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes</article-title>
                  <source>Oncotarget</source>
                  <year>2017</year>
                  <volume>8</volume>
                  <fpage>55039</fpage>
                  <?supplied-pmid 28903400?>
                  <pub-id pub-id-type="pmid">28903400</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Espiritu</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>ZH</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Mazzone</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Hyperglycemia and advanced glycosylation end products suppress adipocyte apoE expression: implications for adipocyte triglyceride metabolism</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2010</year>
                  <volume>299</volume>
                  <fpage>E615</fpage>
                  <lpage>E623</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00273.2010</pub-id>
                  <?supplied-pmid 20647555?>
                  <pub-id pub-id-type="pmid">20647555</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>C-H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>AGE-induced interference of glucose uptake and transport as a possible cause of insulin resistance in adipocytes</article-title>
                  <source>J. Agric. Food Chem.</source>
                  <year>2011</year>
                  <volume>59</volume>
                  <fpage>7978</fpage>
                  <lpage>7984</lpage>
                  <pub-id pub-id-type="doi">10.1021/jf201271y</pub-id>
                  <?supplied-pmid 21650468?>
                  <pub-id pub-id-type="pmid">21650468</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fabbrini</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity</article-title>
                  <source>Proc. Natl. Acad. Sci. USA</source>
                  <year>2009</year>
                  <volume>106</volume>
                  <fpage>15430</fpage>
                  <lpage>15435</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.0904944106</pub-id>
                  <?supplied-pmid 19706383?>
                  <pub-id pub-id-type="pmid">19706383</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Herman</surname>
                      <given-names>MA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism</article-title>
                  <source>Nature</source>
                  <year>2012</year>
                  <volume>484</volume>
                  <fpage>333</fpage>
                  <pub-id pub-id-type="doi">10.1038/nature10986</pub-id>
                  <?supplied-pmid 22466288?>
                  <pub-id pub-id-type="pmid">22466288</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shepherd</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Kahn</surname>
                      <given-names>BB</given-names>
                    </name>
                  </person-group>
                  <article-title>Glucose transporters and insulin action—implications for insulin resistance and diabetes mellitus</article-title>
                  <source>N. Engl. J. Med.</source>
                  <year>1999</year>
                  <volume>341</volume>
                  <fpage>248</fpage>
                  <lpage>257</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJM199907223410406</pub-id>
                  <?supplied-pmid 10413738?>
                  <pub-id pub-id-type="pmid">10413738</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Song</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice</article-title>
                  <source>Diabetes</source>
                  <year>2014</year>
                  <volume>63</volume>
                  <fpage>1948</fpage>
                  <lpage>1965</lpage>
                  <pub-id pub-id-type="doi">10.2337/db13-1636</pub-id>
                  <?supplied-pmid 24520121?>
                  <pub-id pub-id-type="pmid">24520121</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Soro-Paavonen</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes</article-title>
                  <source>Diabetes</source>
                  <year>2008</year>
                  <volume>57</volume>
                  <fpage>2461</fpage>
                  <lpage>2469</lpage>
                  <pub-id pub-id-type="doi">10.2337/db07-1808</pub-id>
                  <?supplied-pmid 18511846?>
                  <pub-id pub-id-type="pmid">18511846</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miranda</surname>
                      <given-names>ER</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2017</year>
                  <volume>313</volume>
                  <fpage>E631</fpage>
                  <lpage>E640</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00146.2017</pub-id>
                  <?supplied-pmid 28811295?>
                  <pub-id pub-id-type="pmid">28811295</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dozio</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Expression of the Receptor for Advanced Glycation End Products in Epicardial Fat: Link with Tissue Thickness and Local Insulin Resistance in Coronary Artery Disease</article-title>
                  <source>J. Diabetes Res.</source>
                  <year>2016</year>
                  <volume>2016</volume>
                  <fpage>2327341</fpage>
                  <pub-id pub-id-type="doi">10.1155/2016/2327341</pub-id>
                  <?supplied-pmid 26788516?>
                  <pub-id pub-id-type="pmid">26788516</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rodiño-Janeiro</surname>
                      <given-names>BK</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Receptor for advanced glycation end-products expression in subcutaneous adipose tissue is related to coronary artery disease</article-title>
                  <source>Eur. J. Endocrinol.</source>
                  <year>2011</year>
                  <volume>164</volume>
                  <fpage>529</fpage>
                  <lpage>537</lpage>
                  <pub-id pub-id-type="doi">10.1530/EJE-10-0904</pub-id>
                  <?supplied-pmid 21282351?>
                  <pub-id pub-id-type="pmid">21282351</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cai</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Ji</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Meyer</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>van der Westhuyzen</surname>
                      <given-names>DR</given-names>
                    </name>
                  </person-group>
                  <article-title>Scavenger receptor CD36 expression contributes to adipose tissue inflammation and cell death in diet-induced obesity</article-title>
                  <source>PLoS One</source>
                  <year>2012</year>
                  <volume>7</volume>
                  <fpage>e36785</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0036785</pub-id>
                  <?supplied-pmid 22615812?>
                  <pub-id pub-id-type="pmid">22615812</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Furuhashi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ura</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Nakata</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Shimamoto</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Insulin sensitivity and lipid metabolism in human CD36 deficiency</article-title>
                  <source>Diabetes Care</source>
                  <year>2003</year>
                  <volume>26</volume>
                  <fpage>471</fpage>
                  <lpage>474</lpage>
                  <pub-id pub-id-type="doi">10.2337/diacare.26.2.471</pub-id>
                  <?supplied-pmid 12547883?>
                  <pub-id pub-id-type="pmid">12547883</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pravenec</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension</article-title>
                  <source>Physiol. Res.</source>
                  <year>2003</year>
                  <volume>52</volume>
                  <fpage>681</fpage>
                  <lpage>688</lpage>
                  <?supplied-pmid 14640889?>
                  <pub-id pub-id-type="pmid">14640889</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chiu</surname>
                      <given-names>TT</given-names>
                    </name>
                    <name>
                      <surname>Jensen</surname>
                      <given-names>TE</given-names>
                    </name>
                    <name>
                      <surname>Sylow</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Richter</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Klip</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Rac1 signalling towards GLUT4/glucose uptake in skeletal muscle</article-title>
                  <source>Cell. Signal.</source>
                  <year>2011</year>
                  <volume>23</volume>
                  <fpage>1546</fpage>
                  <lpage>1554</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cellsig.2011.05.022</pub-id>
                  <?supplied-pmid 21683139?>
                  <pub-id pub-id-type="pmid">21683139</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>JeBailey</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling</article-title>
                  <source>Mol. Endocrinol.</source>
                  <year>2004</year>
                  <volume>18</volume>
                  <fpage>359</fpage>
                  <lpage>372</lpage>
                  <pub-id pub-id-type="doi">10.1210/me.2003-0294</pub-id>
                  <?supplied-pmid 14615606?>
                  <pub-id pub-id-type="pmid">14615606</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marcusohn</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Isakoff</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Rose</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Symons</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Skolnik</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>The GTP-binding protein Rac does not couple PI 3-kinase to insulin-stimulated glucose transport in adipocytes</article-title>
                  <source>Curr. Biol.</source>
                  <year>1995</year>
                  <volume>5</volume>
                  <fpage>1296</fpage>
                  <lpage>1302</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0960-9822(95)00256-9</pub-id>
                  <?supplied-pmid 8574587?>
                  <pub-id pub-id-type="pmid">8574587</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tao</surname>
                      <given-names>W</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Lipid-induced muscle insulin resistance is mediated by GGPPS via modulation of the RhoA/Rho kinase signaling pathway</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2015</year>
                  <volume>290</volume>
                  <fpage>20086</fpage>
                  <lpage>20097</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M115.657742</pub-id>
                  <?supplied-pmid 26112408?>
                  <pub-id pub-id-type="pmid">26112408</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kong</surname>
                      <given-names>X</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Glucagon-like peptide 1 stimulates insulin secretion via inhibiting RhoA/ROCK signaling and disassembling glucotoxicity-induced stress fibers</article-title>
                  <source>Endocrinology</source>
                  <year>2014</year>
                  <volume>155</volume>
                  <fpage>4676</fpage>
                  <lpage>4685</lpage>
                  <pub-id pub-id-type="doi">10.1210/en.2014-1314</pub-id>
                  <?supplied-pmid 25243854?>
                  <pub-id pub-id-type="pmid">25243854</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hara</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that may involve mechanical stretch</article-title>
                  <source>Sci. Signal.</source>
                  <year>2011</year>
                  <volume>4</volume>
                  <fpage>ra3</fpage>
                  <lpage>ra3</lpage>
                  <pub-id pub-id-type="doi">10.1126/scisignal.2001227</pub-id>
                  <?supplied-pmid 21266714?>
                  <pub-id pub-id-type="pmid">21266714</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>SH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistance</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2014</year>
                  <volume>306</volume>
                  <fpage>E332</fpage>
                  <lpage>343</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00619.2013</pub-id>
                  <?supplied-pmid 24326423?>
                  <pub-id pub-id-type="pmid">24326423</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leguina-Ruzzi</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Increased RhoA/Rho-Kinase activity and markers of endothelial dysfunction in young adult subjects with metabolic syndrome</article-title>
                  <source>Metab. Syndr. Relat. Disord.</source>
                  <year>2015</year>
                  <volume>13</volume>
                  <fpage>373</fpage>
                  <lpage>380</lpage>
                  <pub-id pub-id-type="doi">10.1089/met.2015.0061</pub-id>
                  <?supplied-pmid 26512756?>
                  <pub-id pub-id-type="pmid">26512756</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Soliman</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Attenuation of obesity-induced insulin resistance in mice with heterozygous deletion of ROCK2</article-title>
                  <source>Int. J. Obes.</source>
                  <year>2016</year>
                  <volume>40</volume>
                  <fpage>1435</fpage>
                  <pub-id pub-id-type="doi">10.1038/ijo.2016.89</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Feng</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>LoGrasso</surname>
                      <given-names>PV</given-names>
                    </name>
                    <name>
                      <surname>Defert</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>RJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Rho kinase (ROCK) inhibitors and their therapeutic potential</article-title>
                  <source>J. Med. Chem.</source>
                  <year>2015</year>
                  <volume>59</volume>
                  <fpage>2269</fpage>
                  <lpage>2300</lpage>
                  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b00683</pub-id>
                  <?supplied-pmid 26486225?>
                  <pub-id pub-id-type="pmid">26486225</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nakamura</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Marked increase of insulin gene transcription by suppression of the Rho/Rho-kinase pathway</article-title>
                  <source>Biochem. Biophys. Res. Commun.</source>
                  <year>2006</year>
                  <volume>350</volume>
                  <fpage>68</fpage>
                  <lpage>73</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.08.192</pub-id>
                  <?supplied-pmid 16996478?>
                  <pub-id pub-id-type="pmid">16996478</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schinzari</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2012</year>
                  <volume>303</volume>
                  <fpage>E806</fpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00206.2012</pub-id>
                  <?supplied-pmid 22829585?>
                  <pub-id pub-id-type="pmid">22829585</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <mixed-citation publication-type="other">Hudson, B. I. <italic>et al</italic>. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. <italic>J. Biol. Chem</italic> (2008).</mixed-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rai</surname>
                      <given-names>V</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Signal Transduction in Receptor for Advanced Glycation End Products (RAGE)</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2012</year>
                  <volume>287</volume>
                  <fpage>5133</fpage>
                  <lpage>5144</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M111.277731</pub-id>
                  <?supplied-pmid 22194616?>
                  <pub-id pub-id-type="pmid">22194616</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sen</surname>
                      <given-names>B</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Intranuclear actin structure modulates mesenchymal stem cell differentiation</article-title>
                  <source>Stem Cells Dev.</source>
                  <year>2017</year>
                  <volume>35</volume>
                  <fpage>1624</fpage>
                  <lpage>1635</lpage>
                  <pub-id pub-id-type="doi">10.1002/stem.2617</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fujimoto</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: epidermal–dermal interaction in acquired perforating dermatosis</article-title>
                  <source>J. Invest. Dermatol.</source>
                  <year>2010</year>
                  <volume>130</volume>
                  <fpage>405</fpage>
                  <lpage>414</lpage>
                  <pub-id pub-id-type="doi">10.1038/jid.2009.269</pub-id>
                  <?supplied-pmid 19865095?>
                  <pub-id pub-id-type="pmid">19865095</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Girton</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Oegema</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Tranquillo</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>The Japanese Society for Biomaterials, &amp; Biomaterials, T. A. S. f. Exploiting glycation to stiffen and strengthen tissue equivalents for tissue engineering</article-title>
                  <source>J. Biomed. Mater. Res.</source>
                  <year>1999</year>
                  <volume>46</volume>
                  <fpage>87</fpage>
                  <lpage>92</lpage>
                  <pub-id pub-id-type="doi">10.1002/(SICI)1097-4636(199907)46:1&lt;87::AID-JBM10&gt;3.0.CO;2-K</pub-id>
                  <?supplied-pmid 10357139?>
                  <pub-id pub-id-type="pmid">10357139</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ziske</surname>
                      <given-names>MA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids</article-title>
                  <source>Biochem. Biophys. Res. Commun.</source>
                  <year>2016</year>
                  <volume>472</volume>
                  <fpage>33</fpage>
                  <lpage>39</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.02.049</pub-id>
                  <?supplied-pmid 26898799?>
                  <pub-id pub-id-type="pmid">26898799</pub-id>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arden</surname>
                      <given-names>JD</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Small-molecule agonists of mammalian Diaphanous–related (mDia) formins reveal an effective glioblastoma anti-invasion strategy</article-title>
                  <source>Mol. Biol. Cell</source>
                  <year>2015</year>
                  <volume>26</volume>
                  <fpage>3704</fpage>
                  <lpage>3718</lpage>
                  <pub-id pub-id-type="doi">10.1091/mbc.E14-11-1502</pub-id>
                  <?supplied-pmid 26354425?>
                  <pub-id pub-id-type="pmid">26354425</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chamberlain</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Rhinehart</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Shaefer</surname>
                      <given-names>CF</given-names>
                    </name>
                    <name>
                      <surname>Neuman</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes</article-title>
                  <source>Ann. Intern. Med.</source>
                  <year>2016</year>
                  <volume>164</volume>
                  <fpage>542</fpage>
                  <lpage>552</lpage>
                  <pub-id pub-id-type="doi">10.7326/M15-3016</pub-id>
                  <?supplied-pmid 26928912?>
                  <pub-id pub-id-type="pmid">26928912</pub-id>
                </element-citation>
              </ref>
              <ref id="CR63">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Booth</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Acellular normal and fibrotic human lung matrices as a culture system for <italic>in vitro</italic> investigation</article-title>
                  <source>Am. J. Respir. Crit. Care Med.</source>
                  <year>2012</year>
                  <volume>186</volume>
                  <fpage>866</fpage>
                  <lpage>876</lpage>
                  <pub-id pub-id-type="doi">10.1164/rccm.201204-0754OC</pub-id>
                  <?supplied-pmid 22936357?>
                  <pub-id pub-id-type="pmid">22936357</pub-id>
                </element-citation>
              </ref>
              <ref id="CR64">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Han</surname>
                      <given-names>TTY</given-names>
                    </name>
                    <name>
                      <surname>Toutounji</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Amsden</surname>
                      <given-names>BG</given-names>
                    </name>
                    <name>
                      <surname>Flynn</surname>
                      <given-names>LE</given-names>
                    </name>
                  </person-group>
                  <article-title>Adipose-derived stromal cells mediate <italic>in vivo</italic> adipogenesis, angiogenesis and inflammation in decellularized adipose tissue bioscaffolds</article-title>
                  <source>Biomaterials</source>
                  <year>2015</year>
                  <volume>72</volume>
                  <fpage>125</fpage>
                  <lpage>137</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biomaterials.2015.08.053</pub-id>
                  <?supplied-pmid 26360790?>
                  <pub-id pub-id-type="pmid">26360790</pub-id>
                </element-citation>
              </ref>
              <ref id="CR65">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Porzionato</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Sfriso</surname>
                      <given-names>M. M.</given-names>
                    </name>
                    <name>
                      <surname>Macchi</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Rambaldo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Lago</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Lancerotto</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Vindigni</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>De Caro</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Decellularized omentum as novel biologic scaffold for reconstructive surgery and regenerative medicine</article-title>
                  <source>European Journal of Histochemistry</source>
                  <year>2013</year>
                  <volume>57</volume>
                  <issue>1</issue>
                  <fpage>4</fpage>
                  <pub-id pub-id-type="doi">10.4081/ejh.2013.e4</pub-id>
                </element-citation>
              </ref>
              <ref id="CR66">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Erler</surname>
                      <given-names>JT</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche</article-title>
                  <source>Cancer Cell</source>
                  <year>2009</year>
                  <volume>15</volume>
                  <fpage>35</fpage>
                  <lpage>44</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ccr.2008.11.012</pub-id>
                  <?supplied-pmid 19111879?>
                  <pub-id pub-id-type="pmid">19111879</pub-id>
                </element-citation>
              </ref>
              <ref id="CR67">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kent</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Light</surname>
                      <given-names>ND</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation <italic>in vitro</italic></article-title>
                  <source>Biochem. J.</source>
                  <year>1985</year>
                  <volume>225</volume>
                  <fpage>745</fpage>
                  <lpage>752</lpage>
                  <pub-id pub-id-type="doi">10.1042/bj2250745</pub-id>
                  <?supplied-pmid 3919711?>
                  <pub-id pub-id-type="pmid">3919711</pub-id>
                </element-citation>
              </ref>
              <ref id="CR68">
                <label>68.</label>
                <mixed-citation publication-type="other">Baker, N. A., Muir, L. A., Lumeng, C. N. &amp; O’Rourke, R. W. In <italic>Thermogenic Fat</italic> 61–76 (Springer, 2017).</mixed-citation>
              </ref>
              <ref id="CR69">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Figueroa</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Kemeny</surname>
                      <given-names>SF</given-names>
                    </name>
                    <name>
                      <surname>Clyne</surname>
                      <given-names>AM</given-names>
                    </name>
                  </person-group>
                  <article-title>Glycated collagen decreased endothelial cell fibronectin alignment in response to cyclic stretch via interruption of actin alignment</article-title>
                  <source>J. Biomech. Eng.</source>
                  <year>2014</year>
                  <volume>136</volume>
                  <fpage>101010</fpage>
                  <pub-id pub-id-type="doi">10.1115/1.4028037</pub-id>
                  <?supplied-pmid 25033159?>
                  <pub-id pub-id-type="pmid">25033159</pub-id>
                </element-citation>
              </ref>
              <ref id="CR70">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Livak</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Schmittgen</surname>
                      <given-names>TD</given-names>
                    </name>
                  </person-group>
                  <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method</article-title>
                  <source>Methods</source>
                  <year>2001</year>
                  <volume>25</volume>
                  <fpage>402</fpage>
                  <lpage>408</lpage>
                  <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>
                  <?supplied-pmid 11846609?>
                  <pub-id pub-id-type="pmid">11846609</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
